Commonwealth Equity Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,301
Closed -$22K 2521
2016
Q4
$22K Sell
10,301
-3,409
-25% -$9.51K ﹤0.01% 2288
2016
Q3
$46K Sell
13,710
-51,840
-79% -$165K ﹤0.01% 2172
2016
Q2
$206K Sell
65,550
-6,656
-9% -$22.2K ﹤0.01% 1938
2016
Q1
$240K Buy
72,206
+1,623
+2% +$5.06K ﹤0.01% 1791
2015
Q4
$250K Sell
70,583
-9,746
-12% -$40.8K ﹤0.01% 1738
2015
Q3
$404K Buy
80,329
+7,863
+11% +$45.1K ﹤0.01% 1366
2015
Q2
$466K Buy
72,466
+10,562
+17% +$70.7K ﹤0.01% 1372
2015
Q1
$435K Buy
61,904
+8,269
+15% +$59.9K ﹤0.01% 1403
2014
Q4
$414K Sell
53,635
-3,170
-6% -$25.1K ﹤0.01% 1379
2014
Q3
$424K Sell
56,805
-13,399
-19% -$124K 0.01% 1352
2014
Q2
$680K Buy
70,204
+7,756
+12% +$69.1K 0.01% 1075
2014
Q1
$519K Buy
62,448
+20,843
+50% +$179K 0.01% 1139
2013
Q4
$351K Buy
41,605
+24,741
+147% +$208K 0.01% 1344
2013
Q3
$134K Buy
16,864
+634
+4% +$5.1K ﹤0.01% 1723
2013
Q2
$125K Buy
+16,230
New +$127K ﹤0.01% 1664

Other funds holding PDLI